Introduction European valvular heart disease guidelines define women as a ‘special group’. To explore what factors have led ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

ViTAA Medical’s aortic surgery planning tool has gained clearance from the US Food and Drug Administration (FDA), ...

The first ever "humanized" model for aortic valve calcification paves the way for testing potential treatments.

Discover how 3-D imaging is revolutionizing heart surgery by enhancing precision, safety, and personalized treatment options.

A woman who received life-saving surgery has backed calls for more donations of heart valves for vital surgeries. NHS Blood ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the 2025 Transcatheter Cardiovascular Therapeutics (TCT) ...

PARTNER 3 may notch a win for transcatheter aortic valve replacement in patients with low surgical risk, according to experts ...

Low-risk patients with severe, symptomatic aortic stenosis show similar clinical outcomes and valve durability ...

Seven-year follow-up data show that transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement have ...